Latest Leukemia & Lymphoma Society Stories
WHITE PLAINS, N.Y., June 27, 2012 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS) was deeply saddened to learn of the death of the supremely talented Nora Ephron, from acute myelogenous leukemia (AML). Ephron had been battling myelodysplastic syndrome (MDS), which then progressed to AML. MDS is a group of diseases of the blood and bone marrow, with varying degrees of severity. Sometimes MDS can develop as a result of treatment for a different cancer. MDS is often a...
WHITE PLAINS, N.Y., June 27, 2012 /PRNewswire/ -- Tap your inner superhero and grab your shield: the inaugural Herothon Half Marathon Series Powered by The Leukemia & Lymphoma Society takes flight this winter! The Leukemia & Lymphoma Society (LLS), which has operated the world's biggest and most successful endurance sports training program, Team In Training (TNT), for the past 24 years, is now spreading its wings with this new endurance series of its own. The Herothon...
Spirited 10-week fundraising competition introduced powerful new techniques to raise money for vital blood cancer research and patient services. SAN FRANCISCO, June 18, 2012 /PRNewswire-USNewswire/ -- The Greater San Francisco Bay Area Chapter of The Leukemia & Lymphoma Society (LLS) announced the results of its 22nd annual "Man & Woman of the Year" campaign - in which candidates introduced innovative fundraising techniques that garnered headlines around the world - at the...
The San Francisco Bay Area chapter of The Leukemia & Lymphoma Society’s (LLS) Team In Training (TNT) was represented once again during the Olympic Torch Relay. San Francisco, CA (PRWEB) June 16, 2012 The London 2012 Olympic Games begin on July 22 and the Olympic Torch Relay is currently underway. Earlier this month, San Francisco Bay Area endurance sports training and charity program, The Leukemia & Lymphoma Society’s (LLS) Team In Training (TNT), was represented once again...
SAN FRANCISCO, June 5, 2012 /PRNewswire-iReach/ -- Motion To Dismiss Cancer, a team formed to raise money for the Roger Royse 2012 Man of The Year campaign benefitting The Leukemia & Lymphoma Society ("LLS"), is announcing the final round of the "2012 Venture Capital Master's Lunch Series" auction where anyone can bid to win private meetings with some of Silicon Valley's top venture capitalists and start-up founders--with all proceeds supporting LLS and its work with blood...
WHITE PLAINS, N.Y., May 24, 2012 /PRNewswire/ -- Making every cent count, students at Walter Johnson High School in Bethesda, Md., raised an incredible $59,029.54 through Pennies for Patients, making them the top fundraiser nationwide in The Leukemia & Lymphoma Society's School & Youth Programs. Across the United States and Canada, 27,482 schools - more than 15.8 million students from kindergarten to high school - participated in the programs during the 2011-12 school year,...
WHITE PLAINS, N.Y., May 9, 2012 /PRNewswire/ -- Actress and singer-songwriter Miranda Cosgrove has been named The Leukemia & Lymphoma Society's National Ambassador for its 2012 Light The Night® Walks and appears in a new public service announcement to promote this important fundraising campaign. "I will walk for my grandmother in hopes of a healthy recovery," said Cosgrove. "I will walk for my fans -- those teens who have battled leukemia -- the most common cancer in teens...
The Greater San Francisco Bay Area Chapter of Team In Training (TNT) recently added the San Diego Triathlon Classic to its fall lineup. The race will be held on September 12, 2012. Sign up with TNT today at http://www.teamintraining.org/sf to start training and help save lives. San Francisco, CA (PRWEB) May 05, 2012 Athletes of the Leukemia & Lymphoma Society’s Team In Training (TNT), the Bay Area’s largest endurance sports training and charity program, now have a new event to...
2012 Venture Capital Master's Lunch Series to Benefit the Leukemia & Lymphoma Society San Francisco, CA (PRWEB) April 29, 2012 Motion To Dismiss Cancer, a team formed to raise money for the 2012 Roger Royse Leukemia & Lymphoma Society (LLS) Man of the Year campaign, announces the second round of the “2012 Venture Capital Master’s Lunch Series” auction where anyone can bid to win one-on-one meetings with some of Silicon Valley’s top venture capitalists and start-up...
WHITE PLAINS, N.Y., April 26, 2012 /PRNewswire/ -- Thanks to funding from The Leukemia & Lymphoma Society (LLS), Epizyme has been advancing DOT1L, a targeted histone methyltransferase inhibitor (HMTi) as a personalized therapeutic for patients with mixed lineage leukemia (MLL). LLS has committed to providing up to $7.5 million in milestone-based funding to Epizyme to support the program through a Phase 1 clinical trial. Epizyme's partnership with Celgene,...
